Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 2. Chronic cerebrovascular diseases.

The evidential base of major neuroprotective drugs (piracetam, cytoflavin, ethylmethylhydroxypyridine succinate, choline alphoscerate, cortexin, cerebrolysin, citicoline, actovegin) in chronic cerebral ischemia is critically reviewed in the article.